Akamai Technologies, Inc. (AKAM) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, AKAM's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

The consensus price target hints at a 26.4% upside potential for Orion Energy Systems (OESX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

ClearSign (CLIR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

From a technical perspective, PLBY Group, Inc. (PLBY) is looking like an interesting pick, as it just reached a key level of support. PLBY's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

The consensus price target hints at a 34.2% upside potential for Keros Therapeutics (KROS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for Immuneering (IMRX) points to a 126.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Life Time Group Holdings (LTH) points to a 46.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Pharming Group (PHAR) points to an 81.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for SkyWest (SKYW) points to a 34.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 58.5% in Amicus Therapeutics (FOLD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for Compass Therapeutics, Inc. (CMPX) points to a 154.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 27.9% in Crexendo (CXDO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for PRA Group (PRAA) points to a 42% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to an 110.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Shares of Deere & Company (DE) fell Wednesday morning after the maker of large farm and construction equipment gave a weak forecast and warned that “difficult market conditions” will continue for a while longer.

L.B. Foster Company remains a "Buy" as strong order flow and attractive valuation support further upside despite mixed recent financials. FSTR's Infrastructure Solutions segment is thriving, offsetting weakness in Rail, Technologies, and Services, with growth driven by steel products and protective coatings. Shares are undervalued both absolutely and relative to peers, with low multiples and ongoing share buybacks enhancing shareholder value.

The online brokerage will launch a futures and derivatives exchange with Susquehanna International Group.

SNV moves closer to its $8.6B merger with PNFP after securing Federal Reserve approval and targeting a Jan. 1, 2026, close.

BWX Technology's surging revenues and major defense wins give it a stronger near-term edge over NuScale Power's early-stage revenues and years-out project milestones.